Palatin Technologies PTN
NASDAQ PTN
$6.89 -0.34 (-4.70%)
At close: Nov 10, 2026 · 4:00 PM EST

Palatin Technologies (PTN) Current Deferred Revenue (2011 - 2017)

Updated

Palatin Technologies' Current Deferred Revenue was $35.05 million in fiscal Q4 2017 (quarter ended Jun 30, 2017).

Analysis

Palatin Technologies (PTN) Current Deferred Revenue (2011 - 2017) Analysis & Trends

From fiscal Q4 2011 onward, Palatin Technologies has reported Current Deferred Revenue for 4 quarters.

  • The fiscal Q4 2017 figure marks the lowest quarterly Current Deferred Revenue since fiscal Q2 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Palatin Technologies 19.54 Mn -13.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 35.05 Mn
Dec 31, 2011 7,396.00
Sep 30, 2011 18,888.00
Jun 30, 2011 46,105.00
API Access

Palatin Technologies Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PTN&period=max&api_key=YOUR_API_KEY